Both in Pharmaceuticals
Damora Therapeutics vs Mineralys Therapeutics
Over the past year DMRA returned −23.1% and MLYS returned −44.9%; their daily moves had a correlation of 0.37.
DMRA −23.1% MLYS −44.9%Growth of $1, one year, split-adjusted
| Metric | DMRA | MLYS |
|---|---|---|
| Price | $21.60 | $15.55 |
| Market cap | $1.33B | $1.37B |
| Today | +0.51% | −14.47% |
| 1 month | +4.6% | −34.2% |
| 6 months | — | −47.6% |
| Year to date | — | −57.2% |
| 1 year | — | −62.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $540.5M | $563.8M |
| Dividend yield | — | — |
| Volatility (60d) | — | 72.0% |
| Short % of float | 11.2% | 11.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).